Digirad gears up for nSPEED trial:
This article was originally published in Clinica
Gamma camera manufacturer Digirad is gearing up to start multicentre trials of its nSPEED technology - an advanced 3D SPECT image reconstruction technique. During the trial, the company hopes to show that nSPEED can cut acquisition time for cardiac SPECT in half, while maintaining clinical results equivalent to or better than 2D reconstruction techniques. The firm said it is currently "striving" to obtain acceptance from the American Society of Nuclear Cardiology and other societies in order to meet accreditation requirements for the product. nSPEED models depth-dependent point response function in an iterative reconstruction algorithm (OSEM), enabling depth-dependent resolution recovery and improving chamber contrast in SPECT images.